Drug
ranibizumab-nuna
Marketed as BYOOVIZ.
Generic name
ranibizumab-nuna
Brand names
BYOOVIZ
First FDA approval
2021-09-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761202 | BYOOVIZ | 2021-09-17 | SAMSUNG BIOEPIS CO LTD |
Manufacturers
SAMSUNG BIOEPIS CO LTD
Frequently asked questions
When was ranibizumab-nuna FDA approved?
Earliest FDA approval on record: 2021-09-17.
What brand names are sold as ranibizumab-nuna?
BYOOVIZ.
Sources
Appeal a ranibizumab-nuna denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com